Shukra Pharma.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE551C01044
  • NSEID:
  • BSEID: 524632
INR
28.99
0.9 (3.2%)
BSENSE

May 29

BSE+NSE Vol: 3.46 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024

stock-summary

Investments

No Investments in the last few periods;

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024

Compare Balance Sheet Results of Shukra Pharma.
Markets Mojo
Figures in Cr
Standalone - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
43.79
4.72
39.07
827.75%
Share Warrants & Outstandings
Total Reserve
19.05
136.68
-117.63
-86.06%
Shareholder's Funds
62.84
141.40
-78.56
-55.56%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
3.11
9.61
-6.50
-67.64%
Secured Loans
1.64
9.61
-7.97
-82.93%
Unsecured Loans
1.48
0.00
1.48
0.00%
Deferred Tax Assets / Liabilities
3.41
4.48
-1.07
-23.88%
Other Long Term Liabilities
0.13
0.00
0.13
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
3.83
-3.83
-100.00%
Total Non-Current Liabilities
6.65
17.93
-11.28
-62.91%
Current Liabilities
Trade Payables
9.22
144.76
-135.54
-93.63%
Other Current Liabilities
4.27
25.77
-21.50
-83.43%
Short Term Borrowings
1.06
156.79
-155.73
-99.32%
Short Term Provisions
2.74
0.00
2.74
0.00%
Total Current Liabilities
17.28
327.32
-310.04
-94.72%
Total Liabilities
86.77
486.65
-399.88
-82.17%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
43.42
79.70
-36.28
-45.52%
Less: Accumulated Depreciation
24.03
27.14
-3.11
-11.46%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
19.40
52.57
-33.17
-63.10%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.95
0.00
1.95
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.76
-0.76
-100.00%
Long Term Loans & Advances
0.00
5.30
-5.30
-100.00%
Other Non Current Assets
0.00
0.49
-0.49
-100.00%
Total Non-Current Assets
21.34
59.12
-37.78
-63.90%
Current Assets Loans & Advances
Current Investments
0.00
0.75
-0.75
-100.00%
Inventories
9.95
239.89
-229.94
-95.85%
Sundry Debtors
8.77
177.12
-168.35
-95.05%
Cash and Bank
12.12
4.82
7.30
151.45%
Other Current Assets
20.17
3.14
17.03
542.36%
Short Term Loans and Advances
14.42
1.82
12.60
692.31%
Total Current Assets
65.43
427.53
-362.10
-84.70%
Net Current Assets (Including Current Investments)
48.14
100.21
-52.07
-51.96%
Total Current Assets Excluding Current Investments
65.43
426.78
-361.35
-84.67%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
86.77
486.65
-399.88
-82.17%
Contingent Liabilities
1.40
0.00
1.40
0.00%
Total Debt
4.18
166.41
-162.23
-97.49%
Book Value per share (adjusted)
1.44
0.00
1.44
0.00%
Annual - Borrowings
Borrowings 4.18 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 32.70% vs -37.99% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.13 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 18.18% vs 0.00% in Mar 2024

Annual - Fixed Assets
Fixed Assets 21.34 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -1.20% vs -1.32% in Mar 2024

Annual - Investments
Investments 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

No Investments in the last few periods;

Annual - Current Assets
Current Assets 65.43 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 16.36% vs 5.95% in Mar 2024